Regulation of Fatty Acid Oxidation by Acetyl-CoA Generated from Glucose Utilization in Isolated Myocytes. Journal of Molecular and Cellular Cardiology (1996) 28, 825-833. The regulation of fatty acid oxidation in isolated myocytes was examined by manipulating mitochondrial acetyl-CoA levels produced by carbohydrate and fatty acid oxidation. -carnitine had no effect on the oxidation of [U- C]palmitate in a concentration-dependent manner. -carnitine (5 m) increased palmitate oxidation by 37%. The phosphodiesterase inhibitor, enoximone (250 ), also increased palmitate oxidation by 51%. Addition of -carnitine to enoximone resulted in a two-fold increase of palmitate oxidation. Whereas, dichloroacetate (DCA, 1 m), which stimulates PDH activity, decreased palmitate oxidation by 25%. Furthermore, the addition of DCA to myocytes preincubated with either -carnitine or enoximone, had no effect on the carnitine-induced stimulation of palmitate, and reduced that of enoximone by 50%. Varied concentrations of DCA decreased the oxidation of palmitate and octanoate; but increased glucose oxidation in myocytes. The rate of efflux of acetylcarnitine was highest when pyruvate was present in the medium compared to efflux rates in presence of palmitate or palmitate plus glucose. Although the addition of -carnitine plus enoximone resulted in a two-fold increase in palmitate oxidation, acetylcarnitine efflux was minimal under these conditions. Acetylcarnitine efflux was highest when pyruvate was present in the medium. These rates were dramatically decreased when myocytes were preincubated with enoximone, despite the stimulation of palmitate oxidation by this compound. These data suggest that: (1) fatty acid oxidation is influenced by acetyl-CoA produced from pyruvate metabolism; (2) -carnitine may be specific for mitochondrial acetyl-CoA derived from pyruvate oxidation; and (3) it is probable that acetyl-CoA from -oxidation of fatty acids is directly channeled into the citric acid cycle.
Introduction lar rates of fatty acid oxidation. It has been suggested that these effects may be mediated through Long-chain fatty acids represent the major substrate for energy production in the normal working heart the inhibition of the pyruvate dehydrogenase complex (PDH, EC 1. 2. 4. 1) by end products of (Neely and Morgan, 1974a) . The relationship between fatty acids and glucose utilization, the glucfatty acid oxidation such as acetyl-CoA and NADH (Wieland, 1983; Behal et al., 1993) . Also, an inose-fatty acid cycle, was proposed by Randle three decades ago (Randle et al., 1963 (Randle et al., , 1964 . According crease in -oxidation leads to accumulation of citrate and subsequent inhibition of glycolysis and to this hypothesis, glucose utilization in skeletal phosphofructokinase (Randle et al., 1964b ; Regen -carnitine decreases acetyl-CoA level by increasing the efflux of mitochondrial acetylcarnitine (Lysiak et al., 1964) . Recent studies with isolated rat heart mitochondria have suggested that the pool of acetylet al., 1986; Lysiak et al., 1988) . DCA increases acetyl-CoA levels by enhancing the PDH activity CoA derived from -oxidation is different from that which is produced from carbohydrate oxidation and stimulating the conversion of pyruvate into acetyl-CoA (Stacpoole, 1992) . The phospho- (Lysiak et al., 1986) . The acetyl-CoA generated from carbohydrate is accessible to carnitine acetyldiesterase inhibitor, enoximone, increases transport of fatty acids across the plasma membrane and transferase to form acetylcarnitine, whereas that produced by -oxidation is more readily available acetyl-CoA production from fatty acid oxidation (Abdel-aleem and Frangakis, 1991; Abdel-aleem et to the Krebs cycle. If this is the case, the proposed regulation of PDH by fatty acid derived acetyl -CoA al., 1991) . needs to be reevaluated, because this acetyl-CoA may be unavailable for PDH regulation. Furthermore, since these previous studies were per-
Materials and Methods
formed with isolated mitochondria, which do not include the entire pathways of glucose and fatty acid Animals metabolism, these findings need to be reevaluated in isolated tissue or cells in which all regulatory Male Sprague-Dawley rats, weighing 200-250 g, mechanisms are operative.
were obtained from Charles River Laboratory Likewise, mechanism of the reverse process, the (Raleigh, NC, USA). Rats were allowed free access decrease of fatty acid oxidation by increase of glucto standard diet and water ad libitum. The animal ose utilization, is not fully understood. Recent eviprotocol was approved by Duke University's Animal dence has been presented suggesting that Use Committee. Animals were killed by dedepression of fatty acid oxidation induced by incapitation. creasing glucose utilization is mediated through the increase of malonyl-CoA concentration in the heart (Awan and Saggerson, 1993; Saddik et al., 1993) . C]pal- (McGarry et al., 1978; Murthy and Pande, 1987) . mitate were purchased from New England Nuclear The sensitivity of CPT I inhibition to malonyl-CoA (Boston, MA, USA). Sigma was the source of bovine in cardiac tissues is much higher than that of liver serum albumin (BSA, essentially fatty acid free). (Cook, 1984) . These studies have suggested that -carnitine was a generous gift from Sigma-Tau activation of PDH by insulin and dichloroacetate Pharmaceuticals, Inc. (Gaithersburg, MD, USA). (DCA) causes an increase in the malonyl-CoA levels Joklik essential medium was purchased from Gibco in the cytosol that may lead to inhibition of fatty Laboratories (NJ, USA). Collagenase type II was acid oxidation. Malonyl-CoA is produced from purchased from Worthington (NJ, USA). acetyl-CoA by acetyl-CoA carboxylase (ACC, EC 6. 4. 1. 2). Cardiac and skeletal muscle tissues contain a specific isoform of this enzyme which is distinct Isolation of myocytes from the liver enzyme (Bianchi, 1990) . Another possible regulatory mechanism for fatty acid oxAdult rat heart myocytes were isolated using the idation is inhibition of 3-ketoacyl-CoA thiolase (EC published method of Frangakis et al. (1980) . Myo-2. 3. 1. 16) by acetyl-CoA produced from the PDH cytes were isolated with Joklik essential medium reaction. Kinetic studies with purified 3-ketoacylcontaining 5.55 m glucose, 25 m NaHCO 3 , CoA thiolase isolated from pig heart tissue have 1.2 m MgCl 2 and 0.5 m CaCl 2 . The viability of revealed that it is inhibited by acetyl-CoA, K i =4  myocytes isolated by this procedure was 80-90% (Schulz, 1985) .
as determined by trypan blue exclusion. The present study was designed to investigate the regulation of glucose and palmitate oxidation in isolated cardiac cells by the mitochondrial acetylCoA produced by carbohydrate and fatty acid metaMetabolic studies using myocytes bolism. Manipulation of acetyl-CoA levels was achieved by using pharmacological agents such as Myocytes (2 mg cell protein) suspended in 0.9 ml of Joklik medium, containing 25 m NaHCO 3 , -carnitine, dichloroacetate (DCA), and enoximone. 5.55 m glucose, 1.2 m MgCl 2 , 0.5 m CaCl 2 and supernatant was dried under nitrogen and immediately prepared for analysis of acetylcarnitine. 10 m HEPES (pH 7.4), were placed in a 25-ml Erlenmeyer flask. Cells were preincubated with the The dried aliquots containing acetylcarnitine were incubated with 100 l of 3 M HCl in n-methanol at desired concentrations of -carnitine, DCA, and enoximone for 10 min at 37°C. To this cell sus-50°C for 15 min in a capped 1-ml glass vial. The esterifying agent was removed by evaporation unpension was added 0.1 ml of a single-labeled metabolic substrate yielding a final concentration of der nitrogen and the derivativized sample was dissolved in 50 l of methanol:glycerol and a cesium ion gun was used for the analysis of acetylcarnitine. This method of analysis is based An injection of 0.4 ml of 1  hyamine hydroxide was administered through the center well septum on the detection of a common fragment ion of acetylcarnitine methyl esters produced by collisionto absorb the released CO 2 , and the reaction was terminated by injecting 0.4 ml of 7% perchloric induced dissociation as previously described by Millington et al. (1991) . Approximately 2 l of acid through the center well into the incubation medium. The flasks were then shaken continuously sample matrix were analysed and the data recorded and processed as previously described. The final for 2 h at 37°C, at which time the plastic center well was removed, placed into a scintillation vial spectra displayed the relative intensities of ions corresponding to the molecular weights of the containing 10 ml of Scinti Verse BD, and counted in a liquid scintillation counter. Control experiments individual acylcarnitine methyl esters. The concentrations of acetylcarnitine corresponding to m/z with NaH 14 CO 3 added to the cell suspension showed that the release of 14 CO 2 was complete 1 h after the 218 were determined based on their intensities relative to the internal standard, labeled acetyladdition of perchloric acid. All results were corrected for non-specific release of 14 CO 2 by subtracting blank carnitine, which corresponds to m/z 221. counts from the counts after addition of radioactive substrate to the cell suspension.
Stock solutions of substrates were prepared by Statistical analysis dissolving glucose or octanoate in a myocyte suspension buffer and by dissolving palmitic acid in Statistical analysis were performed using the paired a solution of defatted serum albumin in the cell t-test and comparing groups to control or compare suspension buffer. The molar ratio of palmitate to groups to each other. A P<0.05 was considered albumin was 2:1.
significant.
Analysis of acetylcarnitine by tandem mass spectrometry

Results
Myocytes (2 mg cell protein) suspended in 0.9 ml Since -carnitine has been shown to decrease acetylCoA levels in mitochondrial preparations, this exof Joklik medium, containing 25 m NaHCO 3 , 5.55 m glucose, 1.2 m MgCl 2 , and 0.5 m CaCl 2 periment was performed to investigate if the changes induced by -carnitine affect glucose and were preincubated with -carnitine (5 m), -carnitine plus enoximone (0.25 m), and DCA (1 m) palmitate oxidation. Glucose and palmitate concentration in this experiment were 5.55 m and alone or in combination with other agents for 10 min at 37°C. Myocytes were then incubated for 0.2 m, respectively. These concentrations represent physiological or near physiological levels of additional 30 min at 37°C after the addition of 0.1 ml of a metabolic substrate such as 0.2 m these substrates. The rate of oxidation of these substrates was determined by measuring the rate of palmitate, 5 m pyruvate, and 5.55 m glucose. At the end of this period, cell suspensions were conversion of [1- nificantly increased palmitate oxidation in a concentration-dependent manner. At a concentration added as internal standard. The mixture was extracted with 0.8 ml methanol, centrifuged and clear of 5 m, -carnitine increased palmitate oxidation palmitate. This experiment is designed to show whether the regulation of mitochondrial acetylCoA level exerts a corresponding effect on palmitate oxidation. Agents such as -carnitine, DCA, and enoximone were used at single concentration which elicit significant effects on glucose and palmitate oxidation according to previous published studies in isolated mitochondria, myocytes, and isolated working heart preparation (8, 9, 21, 22). The effect of -carnitine (5 m), enoximone (0.25 m), DCA (1 m), -carnitine (5 m) plus enoximone (0.25 m), DCA (1 m) plus -carnitine (5 m), DCA (1 m) plus enoximone (0.25), and DCA (1 m) plus enoximone (0.25 m) plus -carnitine (5 m), on palmitate oxidation was determined in (2.47±0.49 v 3.23±0.45). Also, the reduction of palmitate oxidation by DCA in the myocytes which preincubated with -carnitine plus enoximone was at 37°C in a shaking water bath. As shown in Table 2 , the rate of efflux of acetylcarnitine was highest when pyruvate was present in the medium (237±65.7 nmol/mg protein/30 min) compared by 60%. Glucose oxidation was unaffected by -carnitine.
to the efflux rate in presence of palmitate or palmitate plus glucose (38.92±6.31 and Table 1 shows effects of several pharmacological agents that regulate the acetyl-CoA produced from 44.05±3.1 nmol/mg protein/30 min). Although the addition of -carnitine plus enoximone resulted glucose and fatty acid metabolism on oxidation of in a two-fold increase in palmitate oxidation (see Table 1 ), acetylcarnitine efflux was minimal under these conditions. The addition of enoximone to palmitate plus pyruvate incubations significantly decreased the acetylcarnitine efflux compared to incubations performed without enoximone. DCA had a negligible effect on acetylcarnitine efflux in presence of pyruvate and glucose. In absence exogenous medium (data are not shown).
To investigate the possible site of inhibition of fatty acids by DCA, its effect on palmitate and octanoate oxidation was studied in isolated myopreincubated with varied concentrations of -carnitine, then 1 m of DCA was added to myocyte cytes. Octanoate was used in this experiment because, unlike palmitate, its oxidation is independent suspensions. Reactions were initiated by the addition of 0.2 m [1-14 C]palmitate. As shown in on CPT I activity. Figure 2 shows the effect of varied concentrations of DCA on palmitate and octanoate Figure 3 , DCA significantly decreased palmitateinduced stimulation by -carnitine. oxidation in myocytes. The pattern of inhibition of palmitate and octanoate oxidation by varied
To investigate whether induced inhibition of fatty acid oxidation by DCA is accompanied by a corconcentrations of DCA was similar. DCA (at 0.5 m) did not significantly affect the oxidation of either responding increase of glucose utilization, the effect of DCA on glucose oxidation was studied in isolated palmitate or octanoate.
The effect of DCA on palmitate-induced stimumyocytes. As shown in Figure 4 , DCA increased glucose oxidation in a dose-dependent manner. DCA lation by -carnitine was studied in isolated myocytes to investigate if the effect of DCA occurs at at a concentration of 2 m increased glucose oxidation by 49%. all concentrations of -carnitine. Myocytes were acetyl-CoA produced from carbohydrate and fatty acid metabolism. Regulation of mitochondrial acetyl-CoA levels by -carnitine and DCA has been reported previously. -carnitine decreases mitochondrial acetyl-CoA levels by increasing the efflux of acetylcarnitine generated from acetate produced by carbohydrate metabolism (Lysiak et al., 1986; Uziel et al., 1988) . Conversely, DCA increases its level by activating the pyruvate dehydrogenase regulated by the acetyl-CoA derived from pyruvate. Mitochondrial acetyl-CoA may depress oxidation of fatty acid by inactivating 3-ketoacyl-CoA thiolase, the final enzyme of the -oxidation pathway. Acetyl-
Discussion
CoA has been shown to be a potent inhibitor of 3-ketoacyl-CoA thiolase purified from pig heart tisThe regulation of fatty oxidation by L-carnitine and dichloroacetate sue (Schulz, 1985) . The possibility that -carnitine may increase palmitate oxidation by another mechThe present study was designed to examine the anism such as increasing the mitochondrial uptake of palmitate can not be completely ruled out based regulation of palmitate and glucose oxidation in isolated myocytes by regulating the mitochondrial on these experiments. However, the study by Wang et al. has demonstrated several-fold stimulation of the heart is lower by 10-and 100-fold than that of liver from fed and starved animals. However, the palmitoylcarnitine oxidation by -carnitine during state 4 respiration in isolated rat heart mitochondria intracellular content of malonyl-CoA in cardiac tissue which is only 40% less than that of liver (Wang et al., 1991) . Palmitoylcarnitine is a substrate whose oxidation is independent of the cardoes not inhibit CPT I in the heart (McGarry et al., 1989) . This suggests that increased levels of nitine palmitoyltransferase system and dependent on mitochondrial -oxidation system. Thus, its malonyl-CoA induced by DCA may not be accessible to the carnitine palmitoyltransferase (CPT I). stimulation by -carnitine suggests that this compound may regulate fatty acid oxidation at the -oxidation level.
Another possibility, which has been proposed by The specificity of mitochondrial L-carnitine Saddik et al. (1993) , is that DCA decreases palmitate oxidation by increasing malonyl-CoA levels in the The additive stimulation of palmitate oxidation by -carnitine plus enoximone suggests that these comcytosol. Malonyl-CoA is produced from acetyl-CoA in the cytosol by acetyl-CoA carboxylase (ACC) in pounds exert stimulatory effects at different sites in the pathway of fatty acid oxidation. Indeed, cardiac tissues (Wakil et al., 1958) . Findings from the present study and Saddik et al.'s hypothesis enoximone has been shown to increase fatty acid oxidation by enhancing its cellular uptake (Abdelagree on the regulation of fatty acid oxidation by acetyl-CoA derived from carbohydrate utilization.
aleem and Frangakis, 1991; Abdel-aleem et al., 1991) . The stimulation of fatty acid oxidation by The present study suggests direct regulation of fatty acid oxidation by the acetyl-CoA. Whereas, the enoximone has been shown to be independent of its positive inotropic effect in the heart (Abdel-aleem other hypothesis suggests its regulation by cytosolic malonyl-CoA derived from the acetyl-CoA and Frangakis, 1991). It should also be noted that the effect of enoximone on palmitate oxidation in generated from carbohydrate utilization. According to the hypothesis proposed by Saddik et al. (1993) , mitochondria is different from that of myocytes. In isolated rat heart mitochondria, enoximone de--carnitine should increase cytosolic concentrations of malonyl-CoA secondary to increased levels of creases palmitate oxidation by inactivating acylCoA synthetase (Abdel-aleem et al., 1992) . acetylcarnitine, and thereby decrease fatty acid oxidation. The present study demonstrates an inWhereas, in isolated myocytes enoximone stimulates palmitate oxidation. Thus, the overall effect of crease of palmitate oxidation by -carnitine. In addition, DCA decreased the oxidation of octanoate, enoximone in intact myocytes is stimulation of fatty acid oxidation probably by interacting with plasma who's utilization is independent of CPT I activity. These results suggest that the regulation of palmembranes, thereby affecting fatty acid transport. -carnitine may increase fatty acid oxidation by mitate oxidation by -carnitine and DCA is not mediated by CPT I but rather through the -oxtrapping mitochondrial acetyl-CoA generated from pyruvate, thus buffering its inhibitory effect on 3-idation system under these experimental conditions. These findings are also supported by inhibition of ketoacyl-CoA thiolase. These data suggest that the increase or decrease of acetyl-CoA generated from short chain fatty acid substrates such as 3-hydroxybutrate by DCA in cardiac tissues pyruvate causes a corresponding decrease or increase of fatty acid oxidation in isolated myocytes. (McAllister et al., 1973) . If the decrease of fatty acid oxidation by DCA is due to CPT I inhibition by
The effect of -carnitine on glucose oxidation should be examined carefully because this study malonyl-CoA, only long-chain fatty acid oxidation should be depressed. Probably the most supportive was performed with [U-
14
C]glucose where 14 CO 2 is produced from the PDH reaction and the Krebs evidence for the proposed hypothesis comes from the study by Wang et al. (1991) where -carnitine cycle. Broderick et al. (1992) have shown stimulation of glucose oxidation by -carnitine in the increased the oxidation palmitoylcarnitine in the isolated rat heart mitochondria. The oxidation of perfused rat heart preparation. Recent studies from this laboratory have demonstrated stimulation of this substrate is also independent of the CPT I activity. This effect was associated with a cor-PDH complex, decrease of acetyl-CoA flux (generated from carbohydrates) through the Krebs cycle, responding decrease of mitochondrial acetyl-CoA and increase of free CoA-SH. The lack of inhibition and decrease of oxidative glucose metabolism by -carnitine in myocytes (Abde-aleem et al., 1995) . of palmitate oxidation by malonyl-CoA may be due inaccessibility of CPT I to this compound. Cardiac Discrepancies between these studies may be due to using different experimental conditions since CPT I is much more sensitive to malonyl-CoA inhibition than that of liver, K i of this compound in Broderick's study was performed with isolated rat heart preparation using [U-14 C]glucose in presence to be established, but our findings suggest that it is not accessible to CPT I. of 1.2 m palmitate, while the other study was performed with isolated myocytes using [6] [7] [8] [9] [10] [11] [12] [13] [14] C]gluThese findings support our hypothesis that acetylCoA produced by carbohydrate utilization regulates cose in absence of exogenous fatty acids.
Measurement of the efflux of acetylcarnitine from the rate of fatty acid oxidation. Conditions that cause increase or decrease in the activity of the isolated myocytes under conditions which caused stimulation of glucose and palmitate oxidation may PDH complex will lead to a corresponding, increase or decrease of acetyl-CoA, and inhibition or stimuprovide further support for the proposed hypothesis by determining the source of acetylcarnitine aclation of -oxidation. On the other hand, increased utilization of fatty acids such as in starvation or cumulated in the medium. The rate of efflux is highest when pyruvate is present in the medium.
diabetes may cause an increase of the oxidation of acetyl-CoA produced from -oxidation, which may This efflux is markedly decreased when enoximone plus -carnitine is added to the medium and palcause accumulation of the acetyl-CoA produced from pyruvate, thereby resulting in feedback inmitate oxidation is concomitantly stimulated, despite a two-fold increase of palmitate oxidation. Rates hibition of PDH complex and the oxidation of glucose. of efflux of acetylcarnitine produced from pyruvate were decreased in presence of enoximone probably
In conclusion, these data show that: (1) the rate of fatty acid oxidation is influenced by the acetyldue to its inhibition of pyruvate flux through the PDH. It has been previously shown that enoximone
CoA generated from pyruvate metabolism; (2) the mitochondrial carnitine or carnitine acetyldecreases utilization of pyruvate in myocytes (Abdel-aleem and Frangakis, 1991) . These findings transferase may be specific for the acetyl-CoA which is generated from pyruvate oxidation, and (3) the suggest that acetyl-CoA produced by -oxidation is inaccessible to carnitine acetyltransferase system. acetyl-CoA produced from -oxidation is probably directly channeled into the citric acid cycle. Whereas, acetyl-CoA produced from pyruvate is readily accessible to this system. Acetyl-CoA produced from -oxidation probably is channeled directly to the citric acid cycle. This conclusion is
